scispace - formally typeset
D

Donald V. Lightner

Researcher at University of Arizona

Publications -  205
Citations -  13332

Donald V. Lightner is an academic researcher from University of Arizona. The author has contributed to research in topics: Shrimp & Infectious hypodermal and hematopoietic necrosis. The author has an hindex of 58, co-authored 205 publications receiving 12079 citations.

Papers
More filters
Journal ArticleDOI

Taura syndrome in Penaeus vannamei : demonstration of a viral etiology

TL;DR: Comparisons of TSV samples isolated from naturally infected P. vannamei from Hawaii (USA) and Ecuador indicate that the same virus was responsible for the TS epizootics in both of these shrimp growing regions.
Journal ArticleDOI

Purification and characterization of infectious myonecrosis virus of penaeid shrimp.

TL;DR: The causative agent of myonecrosis affecting cultured Penaeus vannamei in Brazil was demonstrated to be a virus after purification of the agent from infected shrimp tissues, and may represent a new dsRNA virus family that infects invertebrate hosts.
Journal ArticleDOI

A viral disease associated with mortalities in hatchery-reared postlarvae of the giant freshwater prawn Macrobrachium rosenbergii

TL;DR: During mortality outbreaks in hatchery-reared Macrobrachium rosenbergii postlarvae in Guadeloupe Island (French West Inbes) during 1997, an associated viral disease was discovered and the agent was subsequently isolated.
Journal ArticleDOI

Experimental Infection of Western Hemisphere Penaeid Shrimp with Asian White Spot Syndrome Virus and Asian Yellow Head Virus

TL;DR: Postlarval shrimp appeared resistant to YHV because no virus-related signs of infection, mortality, or diurnal infections were found in these species.
Journal ArticleDOI

Biosecurity in Shrimp Farming: Pathogen Exclusion through Use of SPF Stock and Routine Surveillance

TL;DR: Stocking shrimp culture facilities with domesticated shrimp stocks that are free of specific diseases (“Specific Pathogen Free” or SPF) and or with stocks resistant to specific disease agents (SPR) is the most important single component of a biosecurity program.